Long-term clinical data, experience supports effectiveness of PRRT for...
More than ten years of published clinical data and personal experience using PRRT-based targeted therapy of neuroendocrine tumors supports the effectiveness of this novel treatment approach and the...
View ArticleSpecialized nerve cells play key role in controlling information flow in the...
Specialized nerve cells, known as somatostatin-expressing (Sst) interneurons, in the outer part of the mammalian brain (or cerebral cortex) — play a key role in controlling how information flows in the...
View ArticleNovel peptide receptor radionuclide therapy improves wellbeing of...
Malignant neuroendocrine tumors, commonly called NETs, are easy to miss and associated with discouraging survival rates and poor quality of life.
View ArticleLexicon announces top-line results from TELECAST Phase 3 study of telotristat...
Lexicon Pharmaceuticals, Inc. announced today that top-line data from its TELECAST Phase 3 study showed results of telotristat etiprate in treating carcinoid syndrome in cancer patients with metastatic...
View ArticleNovartis announces FDA approval of Afinitor for progressive, nonfunctional...
Novartis today announced that the United States Food and Drug Administration approved Afinitor (everolimus) tablets for the treatment of adult patients with progressive, well-differentiated,...
View ArticleAltered circadian somatostatin expression linked to bipolar disorder
Results of the first study of its kind to link abnormalities in circadian rhythms to changes in specific neurotransmitters in people with bipolar disorder will be published this week in the journal...
View ArticleAdvanced imaging kit Netspot gets FDA approval to detect rare neuroendocrine...
The U.S. Food and Drug Administration today approved Netspot, the first kit for the preparation of gallium Ga 68 dotatate injection, a radioactive diagnostic agent for positron emission tomography...
View ArticleClinical study shows improved outcomes for NET patients treated with...
NETTER-1 study, showing clinically meaningful and significant results for Lutathera (77Lu-DOTA0-Tyr3-Octreotate) in patients with metastatic midgut neuroendocrine tumors (NETs). The data will be...
View ArticleGenetic blood test can help predict patient’s respone to neuroendocrine...
Malignant neuroendocrine tumors (NETs) are relatively rare, notoriously difficult to treat, and associated with poor long-term survival. According to research presented at the 2016 Annual Meeting of...
View ArticleMolecular imaging technique could help optimize radiotherapy dose to combat NETs
Aggressive neuroendocrine cancer is something of a dark horse--a rare, elusive and persevering force linked to discouraging long-term survival rates.
View ArticleLong-term clinical data, experience supports effectiveness of PRRT for...
More than ten years of published clinical data and personal experience using PRRT-based targeted therapy of neuroendocrine tumors supports the effectiveness of this novel treatment approach and the...
View ArticleSpecialized nerve cells play key role in controlling information flow in the...
Specialized nerve cells, known as somatostatin-expressing (Sst) interneurons, in the outer part of the mammalian brain (or cerebral cortex) — play a key role in controlling how information flows in the...
View ArticleNovel peptide receptor radionuclide therapy improves wellbeing of...
Malignant neuroendocrine tumors, commonly called NETs, are easy to miss and associated with discouraging survival rates and poor quality of life.
View ArticleResearchers find surprising differences in first-ever whole-brain map of...
Researchers at Penn State College of Medicine have collaborated on the first-ever quantitative whole-brain map of inhibitory neurons in the mouse brain. These brain cells play a crucial role in...
View ArticleFDA approves new radioactive drug for treatment of rare digestive tract cancers
The U.S. Food and Drug Administration today approved Lutathera (lutetium Lu 177 dotatate) for the treatment of a type of cancer that affects the pancreas or gastrointestinal tract called...
View ArticleScientists identify neural circuit that gives rise to anxiety
Neuroscientists at Cold Spring Harbor Laboratory have identified a neural circuit in the amygdala, the brain's seat of emotion processing, that gives rise to anxiety.
View ArticleNew nuclear medicine method appears to effectively detect neuroendocrine tumors
Researchers have shown that a new nuclear medicine procedure could safely and more effectively detect cancerous gastrointestinal and pancreatic neuroendocrine tumors than current methods.
View ArticleNew FDA-approved therapy provides better quality of life for patients with...
Midgut neuroendocrine tumors are a rare type of cancer that develops in the small intestine and colon. Roughly 12,000 people are diagnosed with this disease each year. In January, the United Stated...
View ArticleStudy shows benefits, safety of long-lasting radionuclide therapy for...
A first-in-human study presented at the 2018 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging demonstrates the benefits and safety of a new, long-lasting type of radionuclide...
View ArticleResearchers identify new region in mouse brain that affects appetite and body...
Researchers at A*STAR's Singapore Bioimaging Consortium have identified a new region of the mouse brain called the Tuberal Nucleus, which affects appetite and body weight
View Article